Class II · Moderate risk
Lansoprazole Delayed-Release Orally Disintegrating Tablets
Failed Dissolution Specifications
FDA Drug Recalls
14,806 recalls, newest first
Class III · Low risk
Lidocaine Hydrochloride Oral Topical Solution
Failed viscosity specification - product was below specificcation
Class II · Moderate risk
Losartan Potassium & Hydrochlorothiazide Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Losartan Potassium & Hydrochlorothiazide Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Losartan Potassium & Hydrochlorothiazide Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Losartan Potassium Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Losartan Potassium Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Losartan Potassium Tablets
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits
Class II · Moderate risk
Lidocaine 2.5% and Prilocaine 2.5% Cream
cGMP Deviations
Class III · Low risk
Phenobarbital Elixir
Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content
Class II · Moderate risk
Paracentesis/Thoracentises Tray
cGMP deviations: Temperature abuse
Class II · Moderate risk
Biopsy and Aspiration Tray Bone Marrow Illinois 11GX4
cGMP deviations: Temperature abuse
Class II · Moderate risk
Intralipid
cGMP deviations: Temperature abuse
Class II · Moderate risk
Intralipid
cGMP deviations: Temperature abuse
Class II · Moderate risk
Cefazolin for injection USP
cGMP deviations: Temperature abuse
Class II · Moderate risk
Cefazolin for injection USP
cGMP deviations: Temperature abuse
Class II · Moderate risk
Diprivan (Propofol)
cGMP deviations: Temperature abuse
Class II · Moderate risk
Diprivan (Propofol)
cGMP deviations: Temperature abuse
Class II · Moderate risk
Ofloxacin Otic Solution 0.3%
cGMP deviations: Temperature abuse
Class II · Moderate risk
Tetracaine Hydrochloride Ophthalmic Solution
cGMP deviations: Temperature abuse
Class II · Moderate risk
Geodon for injection
cGMP deviations: Temperature abuse
Class II · Moderate risk
Sumatriptan Succinate Tablets
cGMP deviations: Temperature abuse
Class II · Moderate risk
Metoprolol tablets 50 mg
cGMP deviations: Temperature abuse
Class II · Moderate risk
Pilocarpine HCL Ophthalmic Solution
cGMP deviations: Temperature abuse
Class II · Moderate risk
Tropicamide Ophthalmic Solution
cGMP deviations: Temperature abuse